Oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC) is a malignant epithelial tumor of the oral cavity characterized by squamous differentiation and the potential for local invasion, cervical lymph-node metastasis, and postoperative recurrence.
Oral squamous cell carcinoma (OSCC) is a malignant epithelial tumor of the oral cavity characterized by squamous differentiation and the potential for local invasion, cervical lymph-node metastasis, and postoperative recurrence. Its clinical behavior is influenced by tumor-stage and nodal status, as well as by the tumor microenvironment; cancer-associated fibroblasts at the invasion front have been investigated as prognostic indicators. OSCC may arise from oral epithelial dysplasia, and this subgroup has been reported to show substantial postoperative recurrence even when histopathological features appear favorable.
Management commonly involves surgery, with adjuvant radiotherapy considered according to pathological risk features such as T stage and lymph-node involvement. Cisplatin, fluorouracil, and chemoimmunotherapy are among the treatment approaches studied, while anti-PD-L1 therapy reflects interest in the CD274 molecule and immune-mediated treatment. Current research is also evaluating spatial variation in PD-L1 and c-MET between primary tumors and lymph-node metastases, and examining signaling pathways including STAT3/ITGB8 and CDK1-HOXC10-MTFR2 as potential therapeutic targets. Elastic scattering spectroscopy with machine-learning classification, multi-omics, and biomarker-based risk stratification are being investigated to improve detection of nodal metastasis, prediction of recurrence, and selection of individualized treatment.
Where the papers sit
9 papers from the last 6 months study oral squamous cell carcinoma directly · updated from PubMed 11 Nov 2026
Study type 0 clinical trials · 6 observational · 1 human data · 1 preclinical · 1 unclassified
Themes one subject
Those 9 are all about one subject.
-
Oral Cancer Clinical Research
Clinical management of oral cancer spans staging, diagnosis, biomarkers, treatment, and prognosis. Diagnostic work ranges from contralateral sentinel-node drainage and elastic scattering spectroscopy for cervical nodal metastasis to salivary metabolomics. Treatment studies assess neoadjuvant chemoimmunotherapy and ASC-J9 targeting STAT3/ITGB8. Prognostic work addresses recurrence, PD-L1 and c-MET heterogeneity, MTBC-related signatures, and cancer-associated fibroblasts, without establishing a single advancing strategy.
Papers
The 9 papers from the last 6 months that study oral squamous cell carcinoma directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Oral Cancer Clinical Research (9)
- Contralateral sentinel node drainage patterns in early lateralised oral squamous cell carcinoma - a retrospective study. The British journal of oral & maxillofacial surgery · 30 Oct 2026 PMID 42963172
- Systems toxicology and multi-omics prioritize an MTBC-related computational signature in oral squamous cell carcinoma. Functional & integrative genomics · 26 Oct 2026 PMID 42931959
- Identification of novel salivary metabolite biomarkers for oral squamous cell carcinoma using untargeted UHPLC-MS/MS metabolomic profiling. Molecular omics · 19 Oct 2026 PMID 42895963
- Detection of Cervical Nodal Metastasis in Oral Squamous Cell Carcinoma Using Elastic Scattering Spectroscopy: Ex Vivo Diagnostic Modeling Study. JMIR cancer · 13 Oct 2026 PMID 42868592
- Efficacy and safety of neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: a two-center real-world retrospective cohort study. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 7 Oct 2026 PMID 42843004
- Oral squamous cell carcinoma arising from oral epithelial dysplasia shows high postoperative recurrence despite favorable histopathology. Clinical oral investigations · 28 Sept 2026 PMID 42803846
- Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma. Oral and maxillofacial surgery · 16 Sept 2026 PMID 42747499
- ASC-J9 attenuates the metastatic potential of oral cancer cells by downregulating the STAT3/ITGB8 signaling pathway. European journal of pharmacology · 2 Sept 2026 PMID 42685816
- Cancer-Associated Fibroblasts in Invasion Front Can be a Prognostic Predictor for Oral Squamous Cell Carcinoma. Pathology international · 1 Jun 2026 PMID 42219817
By study type
Observational studies and case reports (6)
- Contralateral sentinel node drainage patterns in early lateralised oral squamous cell carcinoma - a retrospective study. The British journal of oral & maxillofacial surgery · 30 Oct 2026 PMID 42963172
- Identification of novel salivary metabolite biomarkers for oral squamous cell carcinoma using untargeted UHPLC-MS/MS metabolomic profiling. Molecular omics · 19 Oct 2026 PMID 42895963
- Detection of Cervical Nodal Metastasis in Oral Squamous Cell Carcinoma Using Elastic Scattering Spectroscopy: Ex Vivo Diagnostic Modeling Study. JMIR cancer · 13 Oct 2026 PMID 42868592
- Oral squamous cell carcinoma arising from oral epithelial dysplasia shows high postoperative recurrence despite favorable histopathology. Clinical oral investigations · 28 Sept 2026 PMID 42803846
- Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma. Oral and maxillofacial surgery · 16 Sept 2026 PMID 42747499
- Cancer-Associated Fibroblasts in Invasion Front Can be a Prognostic Predictor for Oral Squamous Cell Carcinoma. Pathology international · 1 Jun 2026 PMID 42219817
Human data, design not indexed (1)
- Systems toxicology and multi-omics prioritize an MTBC-related computational signature in oral squamous cell carcinoma. Functional & integrative genomics · 26 Oct 2026 PMID 42931959
Preclinical: animal, cell and lab studies (1)
- ASC-J9 attenuates the metastatic potential of oral cancer cells by downregulating the STAT3/ITGB8 signaling pathway. European journal of pharmacology · 2 Sept 2026 PMID 42685816
Unclassified: not yet indexed with MeSH (1)
- Efficacy and safety of neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: a two-center real-world retrospective cohort study. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 7 Oct 2026 PMID 42843004
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-10-28. Drafted by language models from published abstracts; not medical advice.